| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5587905 | Growth Hormone & IGF Research | 2017 | 8 Pages |
Abstract
PEGylation of IGF-I strongly enhances half-life, reduces the negative GH feedback and hypoglycemia potential, and therefore offers a valuable alternative to rhIGF-I in treatment of relevant diseases.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
H. Kletzl, A. Guenther, A. Höflich, C. Höflich, J. Frystyk, R.F. Staack, E. Schick, C. Wandel, N. Bleich, F. Metzger,